-
Mashup Score: 1
In this systematic review and meta-analysis, NALIRIFOX and FOLFIRINOX were associated with similar PFS and OS as first-line treatment of advanced PDAC, although NALIRIFOX was associated with a different toxicity profile. Careful patient selection, financial toxic effects consideration, and direct co …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 38CTG Labs - NCBI - 5 month(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: clinicaltrials.govCategories: General Medicine News, Hem/OncsTweet-
Thrilled to announce the LOTUS-CC study, which aims to develop novel subtypes of #cachexia, is enrolling nationwide through The @theNCI ‘s NCORP network Special thanks to our funders: @CancerGrand @theNCI @CRUKresearch https://t.co/N74fhUrjQC https://t.co/Mh9dsCylWC
-
-
Mashup Score: 1Cancer Support Community Releases Report on Cancer Cachexia - 2 year(s) ago
Report Highlights Unmet Medical Needs of Patients Facing Unintentional Weight Loss, Muscle Weakness, and Fatigue…
Source: GlobeNewswire News RoomCategories: Latest Headlines, Oncologists1Tweet-
RT @wendyselig: Proud to have authored this important Voice of the Patient report on #cancer #cachexia https://t.co/tWuPHyoXvk
-
-
Mashup Score: 152023 Conference - 2 year(s) ago
Cancer Cachexia Society – 2021 Conference
Source: www.cancercachexiasociety.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @CancerCachexia: The 7th #CancerCachexia Conference heads to beautiful, historic Edinburgh. Save the dates! https://t.co/emvvP6wyAx http…
-
-
Mashup Score: 2Treating Cancer Cachexia: Progress Looks Possible - 2 year(s) ago
Some people with cancer develop cachexia, a wasting syndrome causing dramatic weight loss. Researchers are studying why—and testing new treatments for it.
Source: National Cancer InstituteCategories: Hem/Oncs, Latest HeadlinesTweet-
An excellent primer on #cachexia and the current state of cachexia science. Kudos to Carmen Phillips and @theNCI team. Great read for faculty, trainees, patients and caregivers. @letswinpc @LUNGevity https://t.co/J727JNSYFH https://t.co/bBCjt71Yf0
-
-
Mashup Score: 0
Abstract. Immune checkpoint inhibition is dramatically improving patient outcomes in diverse cancers, many of which responded poorly to traditional cytotoxic agents. Drivers of heterogeneous response to immune checkpoint therapy are poorly characterized. Cachectic cancer patients exhibit elevated pembrolizumab clearance and poor response, highlighting the immense therapeutic challenge posed by…
Categories: Hem/Oncs, Latest HeadlinesTweet-
@pashtoonkasi @intraccsurvivor @ASCO @pashtoonkasi is on to something here. Patients with #cachexia show increased #Immunotherapy clearance and poorer outcomes with checkpoint inhibitor therapy https://t.co/iPqBOziFu7
-
-
Mashup Score: 1CSHL’s Tobias Janowitz helps lead cancer team that won $25 mln in research funding | TBR News Media - 2 year(s) ago
By Daniel Dunaief If a team Cold Spring Harbor Laboratory Assistant Professor Tobias Janowitz co-leads succeeds, researchers will know more about the end stage of numerous types of cancer that involves the loss of tissue and muscle mass. Tobias Janowitz Recently, lead scientists Janowitz; Eileen White, Rutgers Cancer Institute of New Jersey Deputy Director and Chief Scientific Officer; and Dr….
Source: tbrnewsmedia.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @EileenWhitePhD: CSHL’s Tobias Janowitz helps lead cancer team that won $25 mln in research funding https://t.co/rP54ImXnuU via @TBR New…
-
-
Mashup Score: 12Cleveland Clinic Appoints Alex A. Adjei, M.D., Ph.D., as Chair of Taussig Cancer Institute - 2 year(s) ago
Renowned oncologist and researcher joins Cleveland Clinic from Mayo Clinic
Source: Cleveland Clinic NewsroomCategories: Latest Headlines, Oncologists1Tweet-
RT @CleClinicNews: Cleveland Clinic appoints Dr. Alex A. Adjei as the new chair of Taussig Cancer Institute. https://t.co/b6u3NTEPO2
-
-
Mashup Score: 4Looking for Early Warning Signs of Pancreatic Cancer - 2 year(s) ago
Scientists are exploring whether the onset of diabetes may in some cases herald the existence of one of the most deadly of all cancers.
Source: www.nytimes.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Great to see @nytimes discuss linkage between #diabetes and #pancreaticcancer they also discuss here @PanCAN ‘s early detection initiative. https://t.co/iR2LblN8ml
-
-
Mashup Score: 9SARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19 - 2 year(s) ago
COVID-19 is a spectrum of clinical symptoms in humans caused by infection with SARS-CoV-2. The B.1.1.529 Omicron variant is rapidly emerging and has been designated a Variant of Concern (VOC). The variant is highly transmissible and partially or fully evades a spectrum of neutralising antibodies due to a high number of substitutions in the spike glycoprotein. A major question is the relative…
Source: bioRxivCategories: Hem/Oncs, Latest HeadlinesTweet-
Less #cachexia seen in #omicron infected mice compared to #delta #covid19 SARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19 | bioRxiv https://t.co/HlWBd0McQz
-
RT @fedenichetti: @DrR_DUNNE @TumorBoardTues No https://t.co/0zsiLF9Qjd